Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
- 25 June 2020
- journal article
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 7 (2), 75-81
- https://doi.org/10.17709/2409-2231-2020-7-2-7
Abstract
Purpose of the study. To assess the degree of influence of ischemic disorders in the prostate on the level of androgens.Materials and methods. This was an experimental study that included 20 white non-linear sexually Mature rats. All animals were divided into 2 equal groups: main and control (intact). In the main group of animals (n=10), we created a model of chronic ischemic disorders in the prostate by partial ligation of the inferior Vena cava. After 1.5 months, we conducted a hormonal study in all rats (n=20) — determining the concentration of androgens (testosterone, dihydrotestosterone) and estrogens (estradiol) in the blood of animals and prostate tissue.Results. In the blood of animals of both groups, the level of total testosterone and estradiol did not significantly differ (p>0.05). The level of dihydrotestosterone in the blood serum of rats of the main group on the background of ischemia was reduced by 18.1%, compared to the intact group (p>0.05). However, we detected elevated levels of testosterone (p0.05) in prostate tissue against the background of chronic ischemia.Conclusions. Chronic ischemic disorders in the prostate can be an independent pathogenetic factor in the development of BPH. Vascular damage leads to impaired blood flow and hypoxia, with increased tissue concentration of testosterone, which potentiates the development of BPH.Keywords
This publication has 17 references indexed in Scilit:
- A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat modelBMC Complementary and Alternative Medicine, 2019
- Anatomical Characteristics and Variants of Prostatic Artery in Patients of Benign Hyperplasia Prostate by Digital Subtraction AngiographyOpen Access Macedonian Journal of Medical Sciences, 2019
- КОНСЕРВАТИВНАЯ ТЕРАПИЯ ДОБРОКАЧЕСТВЕННОЙ ГИПЕРПЛАЗИИ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫBulletin "Biomedicine and sociology", 2019
- Reproducibility of uroflowmetry results in patients with benign prostatic hyperplasiaUrology and andrology, 2019
- PREVENTION OF BENIGN PROSTATIC HYPERPLASIABulletin "Biomedicine and sociology", 2018
- EPIDEMIOLOGY OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIARUDN Journal of Medicine, 2018
- Structural modifications of the prostate in hypoxia, oxidative stress, and chronic ischemiaKorean Journal of Urology, 2015
- The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)BJU International, 2013
- A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on RefinementLaboratory Animals, 2011
- Atherosclerosis as a risk factor for benign prostatic hyperplasiaBJU International, 2006